ISSN 1671-5411 CN 11-5329/R
Robert N. Foley, Peter A. McCullough. Anemia treatment and left ventricular hypertrophy in non-dialysis chronic kidney disease. J Geriatr Cardiol 2005; 2(4): 195-195.
Citation: Robert N. Foley, Peter A. McCullough. Anemia treatment and left ventricular hypertrophy in non-dialysis chronic kidney disease. J Geriatr Cardiol 2005; 2(4): 195-195.

Anemia treatment and left ventricular hypertrophy in non-dialysis chronic kidney disease

  • Publish Date: 2005-12-28
  • To this day, the target hemoglobin level that minimi/es cardiovascular risk in chronic kidney disease (CKD) patients remains unclear. When one examines the many randomized trials of epoetin therapy in aggregate, enhanced quality of life provides the most cogent argument for hemoglobin levels above 110 g/L. It remains unclear whether treatment of anemia im-proves longevity, or even a surrogate marker (such as left ven-tricular [LV] mass index), especially when applied at earlier phases of CKD.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1903) PDF downloads(1549) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return